4.6 Article

Divalent Metal Ion Differentially Regulates the Sequential Nicking Reactions of the GIY-YIG Homing Endonuclease I-BmoI

Journal

PLOS ONE
Volume 6, Issue 8, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0023804

Keywords

-

Funding

  1. Natural Sciences and Engineering Research Council of Canada [311610-2010]

Ask authors/readers for more resources

Homing endonucleases are site-specific DNA endonucleases that function as mobile genetic elements by introducing double-strand breaks or nicks at defined locations. Of the major families of homing endonucleases, the modular GIY-YIG endonucleases are least understood in terms of mechanism. The GIY-YIG homing endonuclease I-BmoI generates a double-strand break by sequential nicking reactions during which the single active site of the GIY-YIG nuclease domain must undergo a substantial reorganization. Here, we show that divalent metal ion plays a significant role in regulating the two independent nicking reactions by I-BmoI. Rate constant determination for each nicking reaction revealed that limiting divalent metal ion has a greater impact on the second strand than the first strand nicking reaction. We also show that substrate mutations within the I-BmoI cleavage site can modulate the first strand nicking reaction over a 314-fold range. Additionally, in-gel DNA footprinting with mutant substrates and modeling of an I-BmoI-substrate complex suggest that amino acid contacts to a critical GC-2 base pair are required to induce a bottom-strand distortion that likely directs conformational changes for reaction progress. Collectively, our data implies mechanistic roles for divalent metal ion and substrate bases, suggesting that divalent metal ion facilitates the re-positioning of the GIY-YIG nuclease domain between sequential nicking reactions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

Lack of Cas13a inhibition by anti-CRISPR proteins from Leptotrichia prophages

Matthew C. Johnson, Logan T. Hille, Benjamin P. Kleinstiver, Alexander J. Meeske, Joseph Bondy-Denomy

Summary: This article questions the research findings of Lin et al. on CRISPR immunity and Acr proteins, highlighting inconsistencies in the study including inaccurate bioinformatics analyses and the impossibility of constructing certain bacterial strains.

MOLECULAR CELL (2022)

Article Multidisciplinary Sciences

Genome editing in animals with minimal PAM CRISPR-Cas9 enzymes

Jeremy Vicencio, Carlos Sanchez-Bolanos, Ismael Moreno-Sanchez, David Brena, Charles E. Vejnar, Dmytro Kukhtar, Miguel Ruiz-Lopez, Mariona Cots-Ponjoan, Alejandro Rubio, Natalia Rodrigo Melero, Jesus Crespo-Cuadrado, Carlo Carolis, Antonio J. Perez-Pulido, Antonio J. Giraldez, Benjamin P. Kleinstiver, Julian Ceron, Miguel A. Moreno-Mateos

Summary: The authors validated and optimized the use of SpG and SpRY in vivo, expanding the targeting possibilities in animal genomes.

NATURE COMMUNICATIONS (2022)

Article Biotechnology & Applied Microbiology

Precise DNA cleavage using CRISPR-SpRYgests

Kathleen A. Christie, Jimmy A. Guo, Rachel A. Silverstein, Roman M. Doll, Megumu Mabuchi, Hannah E. Stutzman, Jiecong Lin, Linyuan Ma, Russell T. Walton, Luca Pinello, G. Brett Robb, Benjamin P. Kleinstiver

Summary: In this study, the utility of a near-PAMless SpCas9 variant named SpRY as a universal DNA cleavage tool for various cloning applications was explored. It was found that SpRY can cleave DNA in vitro without the need for a PAM, and can cleave DNA at practically any sequence, including sites refractory to cleavage with wild-type SpCas9. The versatility and effectiveness of SpRYgests were illustrated to improve the precision of several cloning workflows, and a rapid and simple one-pot gRNA synthesis protocol was optimized to streamline SpRYgest implementation.

NATURE BIOTECHNOLOGY (2023)

Article Clinical Neurology

SPTSSA variants alter sphingolipid synthesis and cause a complex hereditary spastic paraplegia

Siddharth Srivastava, Hagar Mor Shaked, Kenneth Gable, Sita D. Gupta, Xueyang Pan, Niranjanakumari Somashekarappa, Gongshe Han, Payam Mohassel, Marc Gotkine, Elizabeth Doney, Paula Goldenberg, Queenie K. G. Tan, Yi Gong, Benjamin Kleinstiver, Brian Wishart, Heidi Cope, Claudia Brito Pires, Hannah Stutzman, Rebecca C. Spillmann, Reza Sadjadi, Orly Elpeleg, Chia-Hsueh Lee, Hugo J. Bellen, Simon Edvardson, Florian Eichler, Teresa M. Dunn

Summary: Sphingolipids, abundant in myelin membranes, are crucial for the structural and signalling functions in the mammalian nervous system. Serine palmitoyltransferase (SPTSSA) is the enzyme responsible for the rate-limiting reaction in sphingolipid synthesis and its activity is tightly regulated by ORMDL proteins. Excessive sphingolipid synthesis due to impaired homeostatic regulation of serine palmitoyltransferase was found to be responsible for defects in early brain development and function. SRivastava et al. identified SPTSSA variants that disrupt ORMDL-mediated regulation of SPT, leading to hereditary spastic paraplegia.

BRAIN (2023)

Article Biotechnology & Applied Microbiology

Precise cut-and-paste DNA insertion using engineered type V-K CRISPR-associated transposases

Connor J. Tou, Benno Orr, Benjamin P. Kleinstiver

Summary: We engineered new CRISPR-associated transposases (CASTs) called HELIX, which improves the purity and specificity of DNA insertion, overcoming the limitations of off-target integration and undesired recombination products. HELIX enables efficient and specific integration in human cell contexts.

NATURE BIOTECHNOLOGY (2023)

Article Immunology

CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells

Julie Brault, Taylor Liu, Siyuan Liu, Amanda Lawson, Uimook Choi, Nikita Kozhushko, Vera Bzhilyanskaya, Mara Pavel-Dinu, Ronald J. Meis, Michael A. Eckhaus, Sandra S. Burkett, Marita Bosticardo, Benjamin P. Kleinstiver, Luigi D. Notarangelo, Cicera R. Lazzarotto, Shengdar Q. Tsai, Xiaolin Wu, Gary A. Dahl, Matthew H. Porteus, Harry L. Malech, Suk See De Ravin

Summary: Ex vivo gene therapy has shown significant clinical benefits in treating Inborn errors of Immunity (IEIs) through the use of engineered retroviral vectors. However, concerns regarding potential genotoxicities have arisen due to random vector integrations. The targeted correction through CRISPR-Cas9-based genome editing offers improved precision and safety for functional correction of IEIs.

FRONTIERS IN IMMUNOLOGY (2023)

Article Microbiology

Evolution of CRISPR-associated endonucleases as inferred from resurrected proteins

Borja Alonso-Lerma, Ylenia Jabalera, Sara Samperio, Matias Morin, Almudena Fernandez, Logan T. Hille, Rachel A. Silverstein, Ane Quesada-Ganuza, Antonio Reifs, Sergio Fernandez-Penalver, Yolanda Benitez, Lucia Soletto, Jose A. Gavira, Adrian Diaz, Wim Vranken, Avencia Sanchez-Mejias, Marc Guell, Francisco J. M. Mojica, Benjamin P. Kleinstiver, Miguel A. Moreno-Pelayo, Lluis Montoliu, Raul Perez-Jimenez

Summary: Research reveals that ancient Cas9 protein from extinct bacteria exhibit significant differences in guide RNA and protospacer-adjacent motif requirements compared to modern Cas9 enzymes. Additionally, these ancient Cas9 proteins evolved from nickase to double-strand break activity, have high activity with single-stranded DNA and RNA targets, and are capable of gene editing in human cells.

NATURE MICROBIOLOGY (2023)

Article Immunology

Interleukin-3 coordinates glial-peripheral immune crosstalk to incite multiple sclerosis

Mate G. Kiss, John E. Mindur, Abi G. Yates, Donghoon Lee, John F. Fullard, Atsushi Anzai, Wolfram C. Poller, Kathleen A. Christie, Yoshiko Iwamoto, Vladimir Roudko, Jeffrey Downey, Christopher T. Chan, Pacific Huynh, Henrike Janssen, Achilles Ntranos, Jan D. Hoffmann, Walter Jacob, Sukanya Goswami, Sumnima Singh, David Leppert, Jens Kuhle, Seunghee Kim-Schulze, Matthias Nahrendorf, Benjamin P. Kleinstiver, Fay Probert, Panos Roussos, Filip K. Swirski, Cameron S. McAlpine

Summary: Glial cells and central nervous system-infiltrating leukocytes play a role in multiple sclerosis (MS), and a network involving IL-3:IL-3RA promotes immune cell recruitment to the CNS, exacerbating MS. Astrocytes and infiltrating T cells produce IL-3, while microglia and myeloid cells express IL-3 receptors. IL3RA-expressing myeloid cells with chemotactic programming were found in MS plaques, and the expression of IL3RA and the level of IL-3 correlated with MS severity.

IMMUNITY (2023)

Article Biotechnology & Applied Microbiology

Rescue of hearing by adenine base editing in a humanized mouse model of Usher syndrome type 1F

Cole W. Peters, Killian S. Hanlon, Maryna Ivanchenko, Eric Zinn, Elizabeth F. Linarte, Yaqiao Li, Jonathan M. Levy, David R. Liu, Benjamin P. Kleinstiver, Artur A. Indzhykulian, David P. Corey

Summary: Usher syndrome type 1F (USH1F) is a genetic disorder characterized by congenital hearing and balance loss and progressive vision loss. This study shows that an adenine base editor (ABE) can reverse a specific mutation (R245X) in the PCDH15 gene, restoring its function and improving hearing in a mouse model of USH1F.

MOLECULAR THERAPY (2023)

Article Biochemistry & Molecular Biology

Sniper2L is a high-fidelity Cas9 variant with high activity

Young-hoon Kim, Nahye Kim, Ikenna Okafor, Sungchul Choi, Seonwoo Min, Joonsun Lee, Seung-Min Bae, Keunwoo Choi, Janice Choi, Vinayak Harihar, Youngho Kim, Jin-Soo Kim, Benjamin P. Kleinstiver, Jungjoon K. Lee, Taekjip Ha, Hyongbum Henry Kim

Summary: Researchers have developed an improved version of Sniper-Cas9, called Sniper2L, which combines high specificity with retained high activity for efficient and specific genome editing at a large number of target sequences.

NATURE CHEMICAL BIOLOGY (2023)

Article Genetics & Heredity

Multimodal CRISPR perturbations of GWAS loci associated with coronary artery disease in vascular endothelial cells

Florian Wunnemann, Thierry Fotsing Tadjo, Melissa Beaudoin, Simon Lalonde, Ken Sin Lo, Benjamin P. Kleinstiver, Guillaume Lettre

Summary: Genome-wide association study (GWAS) is a method used to identify genetic variants associated with common human diseases. This study used CRISPR to test if genes located near GWAS-implicated variants in heart attacks influence the functions of vascular endothelial cells. The researchers identified 26 regions in the human genome that both contain heart attack-associated variants and affect endothelial cell functions.

PLOS GENETICS (2023)

Meeting Abstract Biotechnology & Applied Microbiology

CRISPR/Cas Knockout of miR-21 Reduces Glioma Growth

Lisa Nieland, Thomas S. van Solinge, Pike See Cheah, Liza M. Morsett, Joseph El Khoury, Joseph I. Rissman, Benjamin P. Kleinstiver, Marike L. D. Broekman, Xandra O. Breakefield, Erik R. Abels

MOLECULAR THERAPY (2022)

Meeting Abstract Biotechnology & Applied Microbiology

Derepression of the IL-10 Gene via Genome Editing Across Species Towards Clinical Translation in Lung Transplantation

Kumi Mesaki, Stephen Juvet, Jonathan Yeung, Evgueni Ivakine, Zehong Guan, Premalatha Shathasivam, Akhi Akhter, Benjamin Kleinstiver, Jim Hu, Alan Davidson, Marcelo Cypel, Mingyao Liu, Shaf Keshavjee

MOLECULAR THERAPY (2022)

Meeting Abstract Biotechnology & Applied Microbiology

A Novel DNA Oligo-Based Repair Strategy for the Functional Correction of Shwachman-Diamond Syndrome

C. Y. Zhang, K. Wright, O. Gizlenci, D. Klatt, A. Mucci, A. Nguyen, A. Kennedy, C. Y. Ren, S. Q. Liang, P. P. Liu, S. Maitland, B. Kleinstiver, W. Xue, S. Wolfe, D. Bauer, A. Shimamura, C. Brendel

MOLECULAR THERAPY (2022)

Meeting Abstract Biotechnology & Applied Microbiology

Correcting Pathogenic Germline Mutations in Neurofibromatosis Type 1 (NF1) Using Novel Gene Therapies

Stephanie J. Bouley, Francisco Fernandez, Edward J. M. Scullion, Benjamin P. Kleinstiver, James A. Walker

MOLECULAR THERAPY (2022)

No Data Available